Therapeutic applications of calcium electroporation to effectively induce tumor necrosis
The present inventors have shown that electroporation with calcium ions are efficient on cutaneous and subcutaneous nodules. In particular the present inventors here disclose that a solution comprising calcium ions (Ca 2+ ) with a concentration of at least 0.1 M is extremely useful in a method of treating a neoplasm, such as cancer with means for causing transient permeabilization of the cell membranes of at least part of the neoplasm before, during and/or after administration of said solution, wherein said solution is administered with a ratio of 0.2 to 0.8 of the volume of said part of the neoplasm.
1. A method of treating a neoplasm in a subject comprising:
a) administering to a subject having a neoplasm a solution comprising calcium ions (Ca ++ ) with a concentration of at least 0.1 M, wherein said solution is contacted with at least a part of said neoplasm, and wherein the volume of the solution has a ratio of 0.2 to 0.8 of the volume of said part of the neoplasm; and
b) inducing transient permeabilisation of the cell membranes in said part of said neoplasm, wherein said transient permeabilisation commences before, during, or after said administration of said solution.
2. The method according to claim 1 , wherein the calcium ions induce necrosis in at least 30% of the part of the neoplasm exposed to said transient permeabilisation of the cell membranes.
3. The method according to claim 1 , wherein the transient permeabilisation of the cell membranes is induced by electroporation, sonoporation, a hydrodynamics-based procedure or a magnetic field.
4. The method according to claim 1 , wherein the transient permeabilisation of the cell membranes is induced by an electroporation of 200-2000 V/cm; pulse length 0.1-10.0 ms; pulse number 2-20; and pulse frequency 1 Hz-5 kHz.
5. The method according to claim 1 , wherein the transient permeabilisation is induced by sonoporation.
6. The method according to claim 1 , wherein the subject is a mammal.
7. The method according to claim 1 , wherein the neoplasm is a solid tumor.
8. The method according to claim 1 , wherein the neoplasm is a solid tumor having a minimum diameter of 0.5 cm.
9. The method according to claim 1 , wherein the solution is administrated by intratumoral injection or infusion.
10. The method according to claim 1 , wherein the solution further comprises a chemotherapeutic agent or a cytotoxic agent.
11. The method according to claim 1 , wherein the solution is free from a chemotherapeutic agent or a cytotoxic agent.
12. The method according to claim 1 , wherein step a), alone step b) alone, or both of steps a) and b) are repeated one or more times.